AU2014322046A1 - Complex containing oligonucleotide having immunopotentiating activity and use thereof - Google Patents

Complex containing oligonucleotide having immunopotentiating activity and use thereof

Info

Publication number: AU2014322046A1
Authority: AU; Australia
Prior art keywords: complex containing; containing oligonucleotide; immunopotentiating activity; immunopotentiating; activity
Prior art date: 2013-09-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2014322046A

Other versions

AU2014322046B2 (en

Inventor

Taiki AOSHI

Ken Ishii

Yuji Kasuya

Kouji KOBIYAMA

Makoto Koizumi

Takako Niwa

Fumihiko Takeshita

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Daiichi Sankyo Co Ltd

National Institutes of Biomedical Innovation Health and Nutrition

Original Assignee

Daiichi Sankyo Co Ltd

National Institutes of Biomedical Innovation Health and Nutrition

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-09-20

Filing date

2014-09-19

Publication date

2016-04-28

2014-09-19 Application filed by Daiichi Sankyo Co Ltd, National Institutes of Biomedical Innovation Health and Nutrition filed Critical Daiichi Sankyo Co Ltd

2014-09-19 Priority claimed from PCT/JP2014/074835 external-priority patent/WO2015041318A1/en

2016-04-28 Publication of AU2014322046A1 publication Critical patent/AU2014322046A1/en

2021-02-04 Application granted granted Critical

2021-02-04 Publication of AU2014322046B2 publication Critical patent/AU2014322046B2/en

2021-04-16 Priority to AU2021202301A priority Critical patent/AU2021202301B2/en

Status Active legal-status Critical Current

2034-09-19 Anticipated expiration legal-status Critical

Links

AU2014322046A 2013-09-20 2014-09-19 Complex containing oligonucleotide having immunopotentiating activity and use thereof Active AU2014322046B2 (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
AU2021202301A AU2021202301B2 (en)	2013-09-20	2021-04-16	Complex containing oligonucleotide having immunopotentiating activity and use thereof

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2013-196206		2013-09-20
JP2013196206		2013-09-20
PCT/JP2014/074835 WO2015041318A1 (en)	2013-09-20	2014-09-19	Complex containing oligonucleotide having immunopotentiating activity and use thereof

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2021202301A Division AU2021202301B2 (en)	2013-09-20	2021-04-16	Complex containing oligonucleotide having immunopotentiating activity and use thereof

Publications (2)

Publication Number	Publication Date
AU2014322046A1 true AU2014322046A1 (en)	2016-04-28
AU2014322046B2 AU2014322046B2 (en)	2021-02-04

Family

ID=52688965

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU2014322046A Active AU2014322046B2 (en)	2013-09-20	2014-09-19	Complex containing oligonucleotide having immunopotentiating activity and use thereof
AU2021202301A Active AU2021202301B2 (en)	2013-09-20	2021-04-16	Complex containing oligonucleotide having immunopotentiating activity and use thereof

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AU2021202301A Active AU2021202301B2 (en)	2013-09-20	2021-04-16	Complex containing oligonucleotide having immunopotentiating activity and use thereof

Country Status (18)

Country	Link
US (2)	US10202606B2 (en)
EP (3)	EP3572511B1 (en)
JP (4)	JP6525455B2 (en)
KR (2)	KR20220068276A (en)
CN (3)	CN114652739A (en)
AU (2)	AU2014322046B2 (en)
BR (1)	BR112016005966B1 (en)
CA (1)	CA2923806C (en)
ES (2)	ES2960793T3 (en)
MX (2)	MX377368B (en)
MY (1)	MY178288A (en)
NZ (1)	NZ718900A (en)
PH (1)	PH12016500464B1 (en)
PL (1)	PL3048170T3 (en)
RU (2)	RU2723943C2 (en)
SG (2)	SG11201601885WA (en)
TW (3)	TWI798557B (en)
WO (1)	WO2015041318A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP6383740B2 (en) *	2014-02-06	2018-08-29	国立研究開発法人科学技術振興機構	Peptide / β-1,3-glucan complex and pharmaceutical composition containing the same
US20180256630A1 (en) *	2014-12-26	2018-09-13	National Institutes Of Biomedical Innovation, Health And Nutrition	Use of nucleic acid-polysaccharide complexes having immunopotentiating activity as anti-tumor drug
WO2016152767A1 (en) *	2015-03-20	2016-09-29	国立研究開発法人医薬基盤・健康・栄養研究所	CpG SPACER-OLIGONUCLEOTIDE-CONTAINING COMPLEX HAVING IMMUNOPOTENTIATING ACTIVITY, AND USE OF SAME
EP3308800B1 (en) *	2015-06-10	2021-08-25	The University of Tokyo	Adjuvant for vaccines, vaccine, and immunity induction method
CA3001723A1 (en) *	2015-10-15	2017-04-20	City Of Hope	Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof
WO2018147265A1 (en) *	2017-02-07	2018-08-16	京都府公立大学法人	Vaccine against pathogenic gram-negative bacteria
US11793874B2 (en)	2017-03-30	2023-10-24	The University Of Kitakyushu	Immunity-inducing agent and pharmaceutical composition containing same
US11479773B2 (en) *	2017-03-31	2022-10-25	Aichi Medical University	Antisense nucleic acid for inhibiting biosynthesis of chondroitin sulfate
WO2019172419A1 (en) *	2018-03-09	2019-09-12	株式会社マンダム	Method for detecting indicator of immune-related disease
KR102191491B1 (en)	2018-06-20	2020-12-15	(주)큐젠바이오텍	Pharmaceutical compositions comprising beta-glucan-peptide complexes and antibiotics for preventing or treating inflammatory disease
US20220031839A1 (en) *	2018-09-28	2022-02-03	The University Of Kitakyushu	Immunity-inducing agent comprising antigen peptide-adjuvant nucleotide conjugate and pharmaceutical composition comprising same
KR102111039B1 (en) *	2018-10-30	2020-05-14	아주대학교산학협력단	Composition for sublingual administration of curdlan inhibiting antigen specific immune responses
WO2021132528A1 (en)	2019-12-25	2021-07-01	ナパジェンファーマ，インコーポレテッド	Short-chain cpg-containing oligodeoxynucleotide with linked polydeoxyadenylic acid, complex containing said oligodeoxynucleotide, and use thereof
US20230365966A1 (en) *	2020-10-09	2023-11-16	Napajen Pharma, Inc.	Homogeneous beta-1,3-glucan/nucleic acid complexes and use thereof
TW202233245A (en) *	2020-11-12	2022-09-01	日商第一三共股份有限公司	The particle size is controlled, the complex of β-glucan and nucleic acid
EP4388102A4 (en) *	2021-08-16	2025-07-09	Elicio Therapeutics Inc	COMPOSITIONS CONTAINING POLYNUCLEOTIDE AMPHIPHILES AND METHODS OF USE THEREOF
WO2023068104A1 (en) *	2021-10-20	2023-04-27	国立大学法人京都大学	Medical agent including adjuvant and composite of photosensitive molecule and molecule binding to cancer-specific cell surface molecule
JP2025172274A (en) *	2022-10-20	2025-11-26	一般財団法人阪大微生物病研究会	Compositions suitable for use as respiratory syncytial virus vaccines
CN117568339A (en) *	2023-01-19	2024-02-20	华普生物技术(河北)股份有限公司	CpG oligonucleotide and application thereof
WO2024204689A1 (en) *	2023-03-30	2024-10-03	第一三共株式会社	Method for producing lentinan
CN116942808B (en) *	2023-07-21	2024-02-02	北京成大天和生物科技有限公司	Recombinant herpes zoster vaccine composition and preparation method and application thereof
CN119700676A (en) *	2024-12-13	2025-03-28	华中科技大学	Nanoparticle, preparation method and application thereof, and pharmaceutical preparation

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995026204A1 (en)	1994-03-25	1995-10-05	Isis Pharmaceuticals, Inc.	Immune stimulation by phosphorothioate oligonucleotide analogs
US20030026782A1 (en) *	1995-02-07	2003-02-06	Arthur M. Krieg	Immunomodulatory oligonucleotides
US6977245B2 (en) *	1999-04-12	2005-12-20	The United States Of America As Represented By The Department Of Health And Human Services	Oligodeoxynucleotide and its use to induce an immune response
EP1176966B1 (en)	1999-04-12	2013-04-03	THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES	Oligodeoxynucleotide and its use to induce an immune response
WO2001034207A1 (en)	1999-11-10	2001-05-17	Japan Science And Technology Corporation	Gene carriers
US8017742B2 (en)	1999-11-10	2011-09-13	Japan Science And Technology Agency	Gene carrier
AU2002237559B2 (en)	2001-03-13	2006-10-26	Japan Science And Technology Agency	Gene carriers with the use of polysaccharide and process for producing the same
AU2002320762B2 (en) *	2001-05-21	2006-09-21	Intercell Ag	Immunostimulatory oligodeoxynucleic molecules
JP2004107272A (en)	2002-09-19	2004-04-08	Japan Science & Technology Corp	Gene therapy agent
CA2527756C (en)	2003-05-15	2014-05-06	Japan Science And Technology Agency	Immunostimulating agents
KR100558851B1 (en) *	2004-01-08	2006-03-10	학교법인연세대학교	CJ oligodeoxynucleotide variants with increased immunomodulatory capacity
JP4712333B2 (en) *	2004-08-31	2011-06-29	独立行政法人科学技術振興機構	A method for introducing nucleic acids using a hybrid polysaccharide carrier.
JP2007070307A (en)	2005-09-09	2007-03-22	Japan Science & Technology Agency	Immunostimulatory complex
JP4878915B2 (en)	2006-05-25	2012-02-15	独立行政法人科学技術振興機構	Nucleic acid / polysaccharide / carbon nanotube composite
JP2008100919A (en) *	2006-10-17	2008-05-01	Japan Science & Technology Agency	Nucleic acid / polysaccharide complex used for prevention of Th2 cell-related diseases
US7625555B2 (en) *	2007-06-18	2009-12-01	Novagen Holding Corporation	Recombinant human interferon-like proteins
CN102333538B (en)	2008-12-09	2014-01-15	科勒制药集团有限公司	Immunostimulatory oligonucleotides
US8552165B2 (en)	2008-12-09	2013-10-08	Heather Davis	Immunostimulatory oligonucleotides
JP5035808B2 (en)	2009-01-28	2012-09-26	公益財団法人北九州産業学術推進機構	Method for producing ternary composite
CN101745109A (en)	2010-02-01	2010-06-23	云南沃森生物技术股份有限公司	Method for preparing nasal-spray type influenza virus vaccine containing CpG ODN and poly I:G adjuvant
JP5884578B2 (en)	2012-03-16	2016-03-15	富士通株式会社	Accelerator management device, accelerator management method, and input / output device
CN202938106U (en)	2012-11-26	2013-05-15	甘俊辉	Distance sensing variable-light LED (Light Emitting Diode) lamp

2014
- 2014-09-19 JP JP2015537976A patent/JP6525455B2/en active Active
- 2014-09-19 CN CN202210311021.XA patent/CN114652739A/en active Pending
- 2014-09-19 KR KR1020227016729A patent/KR20220068276A/en not_active Ceased
- 2014-09-19 CA CA2923806A patent/CA2923806C/en active Active
- 2014-09-19 SG SG11201601885WA patent/SG11201601885WA/en unknown
- 2014-09-19 EP EP19182054.7A patent/EP3572511B1/en active Active
- 2014-09-19 SG SG10201802199TA patent/SG10201802199TA/en unknown
- 2014-09-19 BR BR112016005966-2A patent/BR112016005966B1/en active IP Right Grant
- 2014-09-19 TW TW109118927A patent/TWI798557B/en active
- 2014-09-19 NZ NZ718900A patent/NZ718900A/en unknown
- 2014-09-19 MY MYPI2016700971A patent/MY178288A/en unknown
- 2014-09-19 MX MX2016003668A patent/MX377368B/en active IP Right Grant
- 2014-09-19 TW TW103132422A patent/TWI696630B/en active
- 2014-09-19 US US15/022,856 patent/US10202606B2/en active Active
- 2014-09-19 EP EP14846493.6A patent/EP3048170B1/en active Active
- 2014-09-19 KR KR1020167009508A patent/KR102400963B1/en active Active
- 2014-09-19 CN CN201480051586.2A patent/CN105683372A/en active Pending
- 2014-09-19 AU AU2014322046A patent/AU2014322046B2/en active Active
- 2014-09-19 EP EP23176351.7A patent/EP4253546A3/en not_active Withdrawn
- 2014-09-19 ES ES19182054T patent/ES2960793T3/en active Active
- 2014-09-19 WO PCT/JP2014/074835 patent/WO2015041318A1/en not_active Ceased
- 2014-09-19 ES ES14846493T patent/ES2749627T3/en active Active
- 2014-09-19 RU RU2016115052A patent/RU2723943C2/en active
- 2014-09-19 TW TW112109803A patent/TW202332452A/en unknown
- 2014-09-19 RU RU2020117033A patent/RU2020117033A/en unknown
- 2014-09-19 PL PL14846493T patent/PL3048170T3/en unknown
- 2014-09-19 CN CN202210310954.7A patent/CN114762695A/en active Pending
2016
- 2016-03-10 PH PH12016500464A patent/PH12016500464B1/en unknown
- 2016-03-18 MX MX2020012133A patent/MX2020012133A/en unknown
2018
- 2018-12-20 US US16/227,902 patent/US11015202B2/en active Active
2019
- 2019-05-02 JP JP2019087177A patent/JP6993649B2/en active Active
2021
- 2021-04-16 AU AU2021202301A patent/AU2021202301B2/en active Active
- 2021-07-20 JP JP2021120059A patent/JP7278551B2/en active Active
2023
- 2023-04-26 JP JP2023071978A patent/JP2023086856A/en active Pending

Publication	Publication Date	Title
AU2014322046A1 (en)	2016-04-28	Complex containing oligonucleotide having immunopotentiating activity and use thereof
EP3048170A4 (en)	2017-05-03	Complex containing oligonucleotide having immunopotentiating activity and use thereof
IL269693A (en)	2019-11-28	Oligonucleotide probes and uses thereof
EP4151259B8 (en)	2025-10-08	Patient interface and aspects thereof
EP3075735A4 (en)	2017-10-18	Glycolurils having functional group and use thereof
EP3804591B8 (en)	2025-03-19	Skin cleanser
EP3004319A4 (en)	2017-01-25	Disposable container and mixing system comprising the container
EP2963056A4 (en)	2017-06-07	Novel insulin analog and use thereof
EP2983600A4 (en)	2017-01-25	Medical systems and methods
IL234628A0 (en)	2014-11-30	Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
EP2994876A4 (en)	2017-01-04	Systems and methods for administering health care systems
EP2828258A4 (en)	2015-08-12	Novelpyridopyrimidine derivatives and use thereof
EP3087057A4 (en)	2017-06-28	Ring-contracted morphinans and the use thereof
EP3024360A4 (en)	2017-02-22	Cutlery dispenser and related methods
EP3042689A4 (en)	2017-05-10	Syringe and syringe set
EP3000449A4 (en)	2017-03-08	Absorbent body and absorbent article containing said absorbent body
EP2981320A4 (en)	2017-03-08	Restorative sleep system
EP3073903A4 (en)	2017-07-12	Displaying activity data
EP3081644A4 (en)	2017-05-24	Modified lipase and use thereof
EP3079783A4 (en)	2017-09-06	Systems and methods for promoting personal health
SG11201504142WA (en)	2015-06-29	Inhibitory oligonucleotide and use thereof
ZA201504405B (en)	2016-11-30	6-chloro-3-(phenyl-d5)-inden-1-one and use thereof
EP3078747A4 (en)	2017-08-02	Peanut-binding nucleic acid molecule and use thereof
EP3075374A4 (en)	2017-05-03	Water-based skin care agent
EP3088413A4 (en)	2017-08-02	Polypeptide and use thereof as delivery carrier